BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1416845)

  • 1. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States.
    Motley M; Sarafian SK; Knapp JS; Zaidi AA; Schmid G
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1639-43. PubMed ID: 1416845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.
    Knapp JS; Back AF; Babst AF; Taylor D; Rice RJ
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1552-5. PubMed ID: 8363390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of Haemophilus ducreyi resistance to trimethoprim-sulfamethoxazole in Rwanda.
    Van Dyck E; Bogaerts J; Smet H; Tello WM; Mukantabana V; Piot P
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1647-8. PubMed ID: 7979300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa.
    Abeck D; Johnson AP; Dangor Y; Ballard RC
    J Antimicrob Chemother; 1988 Oct; 22(4):437-44. PubMed ID: 3264554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of Haemophilus ducreyi to several antibiotics.
    Ismaeel NA
    Microbios; 1993; 74(299):103-9. PubMed ID: 8361391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi.
    Aldridge KE; Cammarata C; Martin DH
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1986-8. PubMed ID: 8239617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance of Haemophilus ducreyi.
    Rutanarugsa A; Vorachit M; Polnikorn N; Jayanetra P
    Southeast Asian J Trop Med Public Health; 1990 Jun; 21(2):185-93. PubMed ID: 2237585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of Haemophilus ducreyi.
    Hammond GW; Lian CJ; Wilt JC; Ronald AR
    Antimicrob Agents Chemother; 1978 Apr; 13(4):608-12. PubMed ID: 307364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of Haemophilus influenzae to amoxicillin/clavulanic acid, erythromycin, cefaclor, and trimethoprim/sulfamethoxazole.
    Doern GV; Chapin KC
    Diagn Microbiol Infect Dis; 1986 Jan; 4(1):37-41. PubMed ID: 3484692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial susceptibility of 103 strains of Haemophilus ducreyi isolated in Johannesburg.
    Bilgeri YR; Ballard RC; Duncan MO; Mauff AC; Koornhof HJ
    Antimicrob Agents Chemother; 1982 Oct; 22(4):686-8. PubMed ID: 6983858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility and characterization of outer membrane proteins of Haemophilus ducreyi isolated in Thailand.
    Taylor DN; Echeverria P; Hanchalay S; Pitarangsi C; Slootmans L; Piot P
    J Clin Microbiol; 1985 Mar; 21(3):442-4. PubMed ID: 3872313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.
    Knapp JS; Wongba C; Limpakarnjanarat K; Young NL; Parekh MC; Neal SW; Buatiang A; Chitwarakorn A; Mastro TD
    Sex Transm Dis; 1997 Mar; 24(3):142-8. PubMed ID: 9132980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins.
    Sanson-Le Pors MJ; Casin I; Ortenberg M; Perol Y
    J Antimicrob Chemother; 1983 Mar; 11(3):271-80. PubMed ID: 6601649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents.
    Jorgensen JH; Doern GV; Thornsberry C; Preston DA; Redding JS; Maher LA; Tubert T
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):27-32. PubMed ID: 3259490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmid-coded ampicillin resistance in Haemophilus ducreyi.
    Thomson JA; Bilgeri YR
    Antimicrob Agents Chemother; 1982 Oct; 22(4):689-92. PubMed ID: 6983859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
    Doern GV; Brueggemann AB; Pierce G; Holley HP; Rauch A
    Antimicrob Agents Chemother; 1997 Feb; 41(2):292-7. PubMed ID: 9021182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic susceptibility survey of Neisseria gonorrhoeae in Thailand.
    Clendennen TE; Echeverria P; Saengeur S; Kees ES; Boslego JW; Wignall FS
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1682-7. PubMed ID: 1416851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Episome profiles and mobilizable beta-lactamase plasmid in Haemophilus ducreyi.
    Prachayasittikul V; Lawung R; Bulow L
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):80-4. PubMed ID: 11023070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993.
    Knapp JS; Washington JA; Doyle LJ; Neal SW; Parekh MC; Rice RJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2194-6. PubMed ID: 7811045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chancroid by clavulanic acid with amoxycillin in patients with beta-lactamase-positive Haemophilus ducreyi infection.
    Fast MV; Nsanze H; D'Costa LJ; Plummer FA; Karasira P; Maclean IW; Ronald AR
    Lancet; 1982 Sep; 2(8297):509-11. PubMed ID: 6125676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.